{"id":34776,"date":"2020-11-09T14:22:04","date_gmt":"2020-11-09T14:22:04","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=34776"},"modified":"2021-03-18T10:03:08","modified_gmt":"2021-03-18T10:03:08","slug":"magnus-gustafsson","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/","title":{"rendered":"Magnus Gustafsson"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n<h2>Magnus Gustafsson<\/h2>\n<h4>Head of Global Business Development at Biovian<\/h4>\n\t<p>Magnus Gustafsson is Head of Global Business Development at Biovian, a Nordic CDMO in the viral vector, recombinant protein and biopharmaceutical aseptic fill space. Prior to joining Biovian, Magnus worked at Cytiva (formerly GE Healthcare Life Sciences) as Director Strategy Search and Evaluation and at Cobra Biologics as Business and Corporate Development Director. Magnus has a scientific background, with more than 20 peer-reviewed articles, and has spent 15 years in various commercial positions executing intra- and extra scientific and corporate collaborations, sales management, project management, business development, partnership negotiations and agreements. Magnus holds an MSc in Biochemical Engineering, a PhD in Medical Biochemistry and Biophysics and an MBA in Business Administration<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus_Gustafsson_Biovian_BioTech_Pharma_Summit_2021_profile_1.jpg\" alt=\"Magnus_Gustafsson_Biovian_BioTech_Pharma_Summit_2021_profile_1\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Magnus_Gustafsson_Biovian_BioTech_Pharma_Summit_2021_profile_1\" onerror=\"this.style.display='none'\" sizes=\"(max-width: 768px) 100vw, 100vw\" srcset=\"data:image\/svg+xml;utf8,<svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/>&#8221; data-srcset=&#8221;https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus_Gustafsson_Biovian_BioTech_Pharma_Summit_2021_profile_1.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus_Gustafsson_Biovian_BioTech_Pharma_Summit_2021_profile_1-201&#215;300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus_Gustafsson_Biovian_BioTech_Pharma_Summit_2021_profile_1-686&#215;1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus_Gustafsson_Biovian_BioTech_Pharma_Summit_2021_profile_1-768&#215;1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus_Gustafsson_Biovian_BioTech_Pharma_Summit_2021_profile_1-630&#215;940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus_Gustafsson_Biovian_BioTech_Pharma_Summit_2021_profile_1-420&#215;627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus_Gustafsson_Biovian_BioTech_Pharma_Summit_2021_profile_1-315&#215;470.jpg 315w&#8221;>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Closed process for aseptic fill without possibility for sterile filtration\n\t<\/h3>\n<div class=\"su-expand su-expand-collapsed su-expand-link-style-default\" data-height=\"200\"><div class=\"su-expand-content su-u-trim\" style=\"color:#333333;max-height:200px;overflow:hidden\">\n<ul>\n<li>Biovian has established several expert fill processes to accommodate aseptic fill finish of valuable drugs and non-sterile filterable drugs with minimal in-line losses. This talk will in particular focus on a closed process for aseptic fill of vaccines, for which sterile filtering is not possible due to the size of the Vaccine modality.<\/li>\n<li>The talk will also include feasibility, installation and commissioning of Biovian&#8217;s new state of the art fill line and it will include fill of BLS2 fill of viruses and viral vectors.<\/li>\n<\/ul>\n<\/div><div class=\"su-expand-link su-expand-link-more\" style=\"text-align:left\"><a href=\"javascript:;\" style=\"color:#0088FF;border-color:#0088FF\"><span style=\"border-color:#0088FF\">Show more<\/span><\/a><\/div><div class=\"su-expand-link su-expand-link-less\" style=\"text-align:left\"><a href=\"javascript:;\" style=\"color:#0088FF;border-color:#0088FF\"><span style=\"border-color:#0088FF\">Show less<\/span><\/a><\/div><\/div>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener noreferrer\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/biovian.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/biovian.com\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener noreferrer\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/magnus-gustafsson-6071a74\/\" target=\"_blank\" rel=\"noopener noreferrer\">Visit Profile<\/a><\/p>\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Magnus Gustafsson Head of Global Business Development at Biovian Magnus Gustafsson is Head of Global Business Development at Biovian, a Nordic CDMO in the viral vector, recombinant protein and biopharmaceutical aseptic fill space. Prior to joining Biovian, Magnus worked at Cytiva (formerly GE Healthcare Life Sciences) as Director Strategy Search and Evaluation and at Cobra&#8230;<\/p>\n","protected":false},"author":1,"featured_media":34777,"parent":34768,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-34776","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Magnus Gustafsson &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Magnus Gustafsson is Head of Global Business Development at Biovian, a Nordic CDMO in the viral vector, recombinant protein and biopharmaceutical aseptic fill space.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Magnus Gustafsson &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Magnus Gustafsson is Head of Global Business Development at Biovian, a Nordic CDMO in the viral vector, recombinant protein and biopharmaceutical aseptic fill space.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-18T10:03:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus-Gustafsson-Biovian.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/\",\"name\":\"Magnus Gustafsson &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus-Gustafsson-Biovian.jpg\",\"datePublished\":\"2020-11-09T14:22:04+00:00\",\"dateModified\":\"2021-03-18T10:03:08+00:00\",\"description\":\"Magnus Gustafsson is Head of Global Business Development at Biovian, a Nordic CDMO in the viral vector, recombinant protein and biopharmaceutical aseptic fill space.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus-Gustafsson-Biovian.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus-Gustafsson-Biovian.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aseptic Processing Technology 2021 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Magnus Gustafsson\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Magnus Gustafsson &#8226; BioTech Pharma Summit","description":"Magnus Gustafsson is Head of Global Business Development at Biovian, a Nordic CDMO in the viral vector, recombinant protein and biopharmaceutical aseptic fill space.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/","og_locale":"en_US","og_type":"article","og_title":"Magnus Gustafsson &#8226; BioTech Pharma Summit","og_description":"Magnus Gustafsson is Head of Global Business Development at Biovian, a Nordic CDMO in the viral vector, recombinant protein and biopharmaceutical aseptic fill space.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-03-18T10:03:08+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus-Gustafsson-Biovian.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/","name":"Magnus Gustafsson &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus-Gustafsson-Biovian.jpg","datePublished":"2020-11-09T14:22:04+00:00","dateModified":"2021-03-18T10:03:08+00:00","description":"Magnus Gustafsson is Head of Global Business Development at Biovian, a Nordic CDMO in the viral vector, recombinant protein and biopharmaceutical aseptic fill space.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus-Gustafsson-Biovian.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Magnus-Gustafsson-Biovian.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/magnus-gustafsson\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Aseptic Processing Technology 2021 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/aseptic-processing-technology-2021-speakers\/"},{"@type":"ListItem","position":3,"name":"Magnus Gustafsson"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/34776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=34776"}],"version-history":[{"count":7,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/34776\/revisions"}],"predecessor-version":[{"id":35927,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/34776\/revisions\/35927"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/34768"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/34777"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=34776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}